Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09GOS
|
||||
Former ID |
DAP000138
|
||||
Drug Name |
Clotrimazole
|
||||
Synonyms |
Canesten; Canestene; Canestine; Canifug; Chlotrimazole; Cimitidine; Clomatin; Clotrimaderm; Clotrimazol; Clotrimazolum; Clotrimeizol; Cutistad; Empecid; Esparol; FemCare; Gynix; Kanesten; Klotrimazole; Lotrimax; Lotrimin; Monobaycuten; Mycelax; Mycelex; Mycofug; Mycosporin; Mykosporin; Nalbix; Pedisafe; Rimazole; Stiemazol; Tibatin; Trimysten; Canesten Cream; Canesten Solution; Clotrimazole Schering Brand; Desamix F; Fem Care; Gyne lotrimin; Lotrimin AF Cream; Lotrimin AF Lotion; Lotrimin AF Solution; Lotrimin Af; Lotrimin Cream; Lotrimin Lotion; Lotrimin Solution; Mycelex Cream; Mycelex G; Mycelex OTC; Mycelex Solution; Mycelex Troches; Mycelex Twin Pack; Myclo Cream; Myclo Solution; Myclo Spray Solution; Schering Brand of Clotrimazole; B 5097; Bay b 9057; Bayer Brand 1 of Clotrimazole; Bayer Brand 2 of Clotrimazole; C 6019; FB 5097; FB b 5097; Mycelex 7; Trivagizole 3; Bay-B 5097; Candid Vaginal (TN); Candinil (TN); Canesten (TN); Canesten 1-Day Therapy; Canesten 3-Day Therapy; Canesten 6-Day Therapy; Clobrate VT (TN); Clotrimazol [INN-Spanish]; Clotrimazolum [INN-Latin]; DRG-0072; Gino-Lotremine; Gyne-Lotrimin; Gyne-Lotrimin 3; Gyne-Lotrimin 3 Combination Pack; Gyne-Lotrimin Combination Pack; Lotrimin (TN); Lotrimin AF Jock-Itch Cream; Mono-baycuten; Mycelex (TN); Mycelex-7; Mycelex-7 Combination Pack; Mycelex-G; Mycelex: MycosporinRimazole; Myclo-Gyne; Neo-Zol Cream; Pan-Fungex; Cancap-VT (TN); Candid - V Gel (TN); Canesten 1-Day Cream Combi-Pak; Canesten Combi-Pak 1-Day Therapy; Canesten Combi-Pak 3-Day Therapy; Clotrimazole (JP15/USP/INN); Clotrimazole [USAN:INN:BAN:JAN]; (Chlorotrityl)imidazole; 1-(o-Chlorotrityl)imidazole
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antifungal Agents
|
||||
Company |
Bayer Pharmaceuticals Corporation
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H17ClN2
|
||||
InChI |
InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H
|
||||
InChIKey |
VNFPBHJOKIVQEB-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 23593-75-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9139, 569393, 602764, 3288050, 4821019, 7847348, 7978978, 8137259, 8149266, 8151819, 10321221, 10514771, 10852037, 11110962, 11110963, 11335840, 11361079, 11364237, 11366799, 11369361, 11371377, 11373989, 11377523, 11447256, 11462051, 11466295, 11467415, 11483912, 11486069, 11487944, 11490175, 11492110, 11495157, 11532882, 11533491, 12146064, 14802606, 17404878, 24278327, 24860592, 26611668, 26680328, 26719636, 26747486, 26747487, 26758479, 29221967, 46386926, 46499864, 46507927
|
||||
ChEBI ID |
ChEBI:3764
|
||||
SuperDrug ATC ID |
A01AB18; D01AC01; G01AF02
|
||||
SuperDrug CAS ID |
cas=023593751
|
||||
Target and Pathway | |||||
Target(s) | High affinity interleukin-8 receptor B | Target Info | Modulator | ||
NetPath Pathway | TNFalpha Signaling Pathway | ||||
Pathway Interaction Database | IL8- and CXCR2-mediated signaling events | ||||
References | |||||
Ref 536838 | Emerging drugs for chemotherapy-induced mucositis. Expert Opin Emerg Drugs. 2008 Sep;13(3):511-22. | ||||
Ref 539475 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2330). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.